Omeros Stock Buy Hold or Sell Recommendation
| OMER Stock | USD 8.62 0.22 2.49% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Omeros is 'Hold'. A buy or sell recommendation provided by Macroaxis is an automated analysis based on historical performance and your stated risk tolerance. It serves as guidance on whether to purchase or sell Omeros within the specified time frame.
Check out Omeros Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in Omeros Stock, please use our How to Invest in Omeros guide. Note, we conduct extensive research on individual companies such as Omeros and provide practical buy, sell, or hold advice based on investors' constraints. Omeros. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
Omeros |
Execute Omeros Buy or Sell Advice
The Omeros recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Omeros. Macroaxis does not own or have any residual interests in Omeros or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Omeros' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Hold
Market Performance | Good | Details | |
Volatility | Relatively risky | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Average | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Omeros Trading Alerts and Improvement Suggestions
| Omeros is way too risky over 90 days horizon | |
| Omeros appears to be risky and price may revert if volatility continues | |
| Omeros has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (117.81 M) with loss before overhead, payroll, taxes, and interest of (37.84 M). | |
| Omeros has a poor financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Omeros Trading Up 5.3 percent - Heres What Happened - MarketBeat |
Omeros current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Omeros analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Omeros analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Average Consensus Buy
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
Omeros Returns Distribution Density
The distribution of Omeros' historical returns is an attempt to chart the uncertainty of Omeros' future price movements. The chart of the probability distribution of Omeros daily returns describes the distribution of returns around its average expected value. We use Omeros price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Omeros returns is essential to provide solid investment advice for Omeros.
| Mean Return | 1.73 | Value At Risk | -10.62 | Potential Upside | 28.19 | Standard Deviation | 12.37 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Omeros historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Omeros Stock Institutional Investors
The Omeros' institutional investors refer to entities that pool money to purchase Omeros' securities or originate loans. These institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds.
| Shares | Royal Bank Of Canada | 2024-09-30 | 497 K | Charles Schwab Investment Management Inc | 2024-09-30 | 485 K | Ubs Group Ag | 2024-09-30 | 450.1 K | Nomura Holdings Inc | 2024-09-30 | 316.3 K | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 297.9 K | Goldman Sachs Group Inc | 2024-09-30 | 178.2 K | Bank Of America Corp | 2024-09-30 | 176.3 K | Bridgeway Capital Management, Llc | 2024-09-30 | 161.3 K | Susquehanna Fundamental Investments, Llc | 2024-06-30 | 156 K | Ingalls & Snyder Llc | 2024-09-30 | 4.5 M | Blackrock Inc | 2024-09-30 | 4.2 M |
Omeros Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | 7.4M | 90.3M | (89.8M) | (3.9M) | (3.5M) | (3.3M) | |
| Free Cash Flow | (100.4M) | (110.0M) | (86.6M) | 74.3M | 66.9M | 70.2M | |
| Depreciation | 1.6M | 1.4M | 952K | 920K | 1.1M | 735.4K | |
| Other Non Cash Items | 25.9M | 1.7M | (30.0M) | (63.0M) | (56.7M) | (53.9M) | |
| Capital Expenditures | 283K | 277K | 113K | 426K | 383.4K | 640.5K | |
| Net Income | (138.1M) | 194.2M | 47.4M | (117.8M) | (106.0M) | (100.7M) | |
| End Period Cash Flow | 10.5M | 100.8M | 11.0M | 7.1M | 8.2M | 12.1M | |
| Change To Inventory | 355K | (1.1M) | (208K) | 34.3M | 39.5M | 41.4M | |
| Investments | (66.7M) | 68.0M | (127.5M) | (197.3M) | (177.6M) | (168.7M) | |
| Change Receivables | (12.4M) | 31.3M | (34.3M) | (175.1M) | (157.6M) | (149.7M) | |
| Net Borrowings | 1.4M | 92.6M | 289K | 40K | 46K | 43.7K | |
| Change To Netincome | 13.8M | 17.1M | (292.9M) | 14.1M | 12.7M | 13.3M |
Omeros Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Omeros or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Omeros' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Omeros stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 1.50 | |
β | Beta against Dow Jones | 2.52 | |
σ | Overall volatility | 12.95 | |
Ir | Information ratio | 0.13 |
Omeros Volatility Alert
Omeros is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Omeros' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Omeros' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Omeros Fundamentals Vs Peers
Comparing Omeros' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Omeros' direct or indirect competition across all of the common fundamentals between Omeros and the related equities. This way, we can detect undervalued stocks with similar characteristics as Omeros or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Omeros' fundamental indicators could also be used in its relative valuation, which is a method of valuing Omeros by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Omeros to competition |
| Fundamentals | Omeros | Peer Average |
| Return On Equity | -5.76 | -0.31 |
| Return On Asset | -0.27 | -0.14 |
| Current Valuation | 588.74 M | 16.62 B |
| Shares Outstanding | 57.95 M | 571.82 M |
| Shares Owned By Insiders | 4.44 % | 10.09 % |
| Shares Owned By Institutions | 42.90 % | 39.21 % |
| Number Of Shares Shorted | 9.27 M | 4.71 M |
| Price To Earning | 0.73 X | 28.72 X |
| Price To Book | 8.44 X | 9.51 X |
| Price To Sales | 4.93 X | 11.42 X |
| Gross Profit | (37.84 M) | 27.38 B |
| EBITDA | (163.61 M) | 3.9 B |
| Net Income | (117.81 M) | 570.98 M |
| Cash And Equivalents | 122.56 M | 2.7 B |
| Cash Per Share | 1.95 X | 5.01 X |
| Total Debt | 361.58 M | 5.32 B |
| Current Ratio | 5.01 X | 2.16 X |
| Book Value Per Share | (2.66) X | 1.93 K |
| Cash Flow From Operations | 74.73 M | 971.22 M |
| Short Ratio | 8.56 X | 4.00 X |
| Earnings Per Share | (3.14) X | 3.12 X |
| Price To Earnings To Growth | (0.17) X | 4.89 X |
| Target Price | 36.0 | |
| Number Of Employees | 198 | 18.84 K |
| Beta | 1.48 | -0.15 |
| Market Capitalization | 512.28 M | 19.03 B |
| Total Asset | 378.27 M | 29.47 B |
| Retained Earnings | (753.53 M) | 9.33 B |
| Working Capital | 306.85 M | 1.48 B |
| Current Asset | 37.15 M | 9.34 B |
| Current Liabilities | 16.25 M | 7.9 B |
| Net Asset | 378.27 M |
Note: Acquisition by Michael Jacobsen of 100000 shares of Omeros at 3.06 subject to Rule 16b-3 [view details]
Omeros Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Omeros . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Daily Balance Of Power | (9,223,372,036,855) | |||
| Rate Of Daily Change | 0.98 | |||
| Day Median Price | 8.62 | |||
| Day Typical Price | 8.62 | |||
| Price Action Indicator | (0.11) | |||
| Period Momentum Indicator | (0.22) |
About Omeros Buy or Sell Advice
When is the right time to buy or sell Omeros? Buying financial instruments such as Omeros Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Omeros in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Health Care ETFs Thematic Idea Now
Health Care ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Health Care ETFs theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Health Care ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Omeros Stock Analysis
When running Omeros' price analysis, check to measure Omeros' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Omeros is operating at the current time. Most of Omeros' value examination focuses on studying past and present price action to predict the probability of Omeros' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Omeros' price. Additionally, you may evaluate how the addition of Omeros to your portfolios can decrease your overall portfolio volatility.